Actividades asistenciales

Self-discharging type environmental sanitation tricycle
16/09/2025 - The invention relates to the technical field of environmental sanitation tricycles, in particular to a self-discharging environmental sanitation tricycle which comprises a compartment and an...
CLAUDIN 18.2 ANTIBODIES, ANTIGEN BINDING FRAGMENTS AND ANTIBODY DRUG CONJUGATES THEREOF AND METHODS OF USE IN CANCER THERAPY
04/06/2026 - Provided are antibodies, antigen binding fragments, and immunoconjugates thereof that specifically bind to claudin 18.2 expressing cells, along with pharmaceutical compositions and kits comprising...
COMBINATION THERAPY FOR THE TARGETED DEGRADATION OF BCL6
04/06/2026 - The present disclosure relates to methods of treating cancer in a subject, comprising administering to the subject an effective amount of Compound A, or a pharmaceutically acceptable salt thereof...
COMBINATION THERAPY FOR THE TARGETED DEGRADATION OF BCL6
04/06/2026 - The present disclosure relates to methods of treating cancer in a subject, comprising administering to the subject an effective amount of Compound A, or a pharmaceutically acceptable salt thereof,...
CANCER
04/06/2026 - The invention relates to cancer therapy, and in particular, to novel polypeptides derived from the oncogenic transcription factor c-MYC (MYC), conjugates thereof, pharmaceutical compositions...
TREATMENT OF ORGAN DYSFUNCTION USING A COMBINATION OF MESENCHYMAL STEM CELLS AND EXOSOMES
07/05/2026 - Embodiments relate to a method of treating a disease or condition in a subject in need thereof, the method comprising: administering a therapeutic effective amount of a pharmaceutical composition...
LOW LACTOSE, LOW SUGAR, MILK-BASED COMPOSITION COMPRISING GOS FOR USE IN IMPROVING METABOLIC HEALTH, IMMUNE HEALTH, BRAIN HEALTH AND/OR PREVENTING AND/OR TREATING GI-DISORDERS OR IMPROVING DIGESTIVE COMFORT IN AN INFANT, YOUNG CHILD OR CHILD
07/05/2026 - Methods and compositions for improving metabolic health, immune health, brain health, and /or treating and/or preventing gastrointestinal disorders and/or improving digestive comfort in an infant,...
ASIATICOSIDE COMPOUND AND PHARMACEUTICAL USE THEREOF
08/05/2026 - Provided are an asiaticoside compound and a pharmaceutical use thereof. The asiaticoside compound comprises a compound having a structural formula as shown in formula (I), a pharmaceutically...
COMPOUND, PHARMACEUTICAL COMPOSITION, AND USE THEREOF IN PREPARATION OF DRUGS FOR TREATING CARDIOVASCULAR AND CEREBROVASCULAR DISEASES
08/05/2026 - The present invention relates to the technical field of medicine, and discloses a compound, a pharmaceutical composition, and a use thereof in preparation of drugs for treating cardiovascular and...
CYCLIC AMINE COMPOUND WITH ARYL SUBSTITUTION AND PREPARATION METHOD THEREFOR AND USE THEREOF
08/05/2026 - Disclosed in the present invention are a cyclic amine compound with an aryl substitution, and a preparation method therefor, and a use thereof. The present invention provides the use of a...
PHARMACEUTICAL COMPOSITION COMPRISING CO2 FOR USE IN THE TREATMENT OF CONDITIONS ASSOCIATED WITH HEADACHE
13/05/2026 - [0001] The present invention relates to a pressurized pharmaceutical composition comprising carbon dioxide (CO<2>) for use in the treatment or prevention of a disorder or condition...
Composition for preventing ameliorating or treating olfactory disorder comprising a radiation irradiated chrysin compound as an active ingredient
13/05/2026 - The present invention relates to a use of nicotinamide adenine dinucleotide (NAD) for preventing or treating olfactory disorders. The NAD increases the thickness of olfactory epithelial tissue and...
CX3CR1 T Tregs engineered to overexpress CX3CR1
12/05/2026 - The present invention relates to uses of regulatory T cells manipulated to overexpress CX3CR1. The regulatory T cells induced to overexpress CX3CR1 according to the present invention reduce...
HIGH-POTENCY GLUCOCORTICOID POLYMORPH, PREPARATION METHOD THEREFOR AND USE THEREOF
12/05/2026 - The present invention relates to a novel polymorph of...
METHODS OF ADMINISTERING A VOLTAGE-GATED POTASSIUM CHANNEL OPENER
14/05/2026 - [0000] The present disclosure provides methods related to the co-administration of a cytochrome P450 3A4 (CYP3A4) inhibitor and Compound A (azetukalner). The combination of the CYP3A4 inhibitor...
METHODS AND COMPOSITIONS FOR CENTRAL NERVOUS SYSTEM (CNS) DRUG DELIVERY AND TREATMENT
14/05/2026 - The disclosure herein provides, in example embodiments, methods and compositions for central nervous system (CNS) drug delivery and treatment comprising administering an infusion solution to a...
C1Q AS TARGET TO TREAT FATIGUE
15/05/2026 - The present invention relates to compounds which are capable to bind the complement component 1, subcomponent q (C1q) and to inhibit its biological activity. More in particular, the present...
DELIVERY OF SAFE AND EFFICACIOUS DOSE OF CHEMOTHERAPY TO THE CNS FOR TREATMENT OF CANCER
15/05/2026 - CED-based methods, products and compositions for treating glioblastoma with anti-inflammatory therapeutics and chemotherapeutics without decreasing brain corticosterone compared to systemic...
METHOD FOR IMPROVING OR REGULATING EMOTIONS AND COMPOSITION
15/05/2026 - A method for improving or regulating subjects' emotions, comprising: administering to subjects a composition comprising an effective amount of anandamide or a derivative thereof before, during, or...
TARGETED PROTEIN DEGRADATION
15/05/2026 - This disclosure features chemical entities (e.g., a compound or a pharmaceutically acceptable salt thereof) that degrade and/or otherwise modulate (e.g., inhibit) NIMA Related Kinase 7 (NEK7)....
PHARMACEUTICAL COMPOSITION FOR PROMOTING MIGRATION OF SUBSTANCE TO CENTRAL NERVOUS SYSTEM
15/05/2026 - Provided is a composition for promoting migration of a target substance to the central nervous system, the composition containing a substance having an inhibitory activity against sphingomyelin...